Regional Immunosuppression in Esophageal Squamous Cancer: Evidence from Functional Studies with Matched Lymph Nodes

Journal of Immunology

Volumn 157, Issue 10, 1996, Pages 4717-4720

  O'Sullivan, Gerald C ^a   Corbett, Anne R ^a   Shanahan, Fergus ^a,b   Collins, J Kevin ^a  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b Department of Medicine National University of Ireland Cork   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANIMAL; ARTICLE; ESOPHAGUS TUMOR; FEMALE; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; LYMPH NODE; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; PATHOLOGY; RABBIT; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; IMMUNE TOLERANCE; LYMPH NODES; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; RABBITS;

EID: 0030588698     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Somers, S. S., and P. J. Guillou. 1991. Cancer and the immune response. In Immunology in Surgical Practice. A. Pollock, ed. Edward Arnold, London, pp. 131-149.
2. Sulitzeanu, D. 1993. Immunosuppressive factors in human cancer. Adv. Cancer Res. 60:247.
3. O'Mahony, A., G. C. O'Sullivan, J. O'Connell, T. G. Cotter, and J. K. Collins. 1993. An immune suppressive factor derived from esophageal squamous carcinoma induces apoptosis in normal and transformed cells of lymphoid lineage. J. Immunol. 151:4847.
4. Moll, R., W. W. Franke, D. L. Schiller, B. Geiger, and R. Krepler. 1982. The catalog of human cytokeratins: pattern of expression in normal epithelia, tumors and cultured cells. Cell 31:11.
5. Riethmüller, G., and J. P. Johnson. 1992. Monoclonal antibodies in the detection and therapy of micrometastatic epithelial cancers. Curr. Opin. Immunol. 4:647.
6. Boyum, A. 1968. Separation of leukocytes from blood and bone marrow. Scand. J. Clin. Lab. Invest. 21:31.
7. Collins, J. K., A. O'Mahony, F. O'Brien, A. Corbett, D. Morrissey, M. O'Donoghue, and G. C. O'Sullivan. 1992. Evaluation of newly established cell lines as models to study growth, invasion and metastatic spread in oesophageal cancer. Fibrinolysis 6(Suppl. 4):83.
8. Reiss, C. K., F. J. Volenec, M. Humphrey, O. Singla, and L. I. Humphrey. 1983. The role of the regional lymph node in breast cancer: a comparison between nodal and systemic reactivity. J. Surg. Oncol. 22:249.
9. Hoon, D. S., E. L. Korn, and A. J. Cochran. 1987. Variations in functional immunocompetence of individual tumor-draining lymph nodes in humans. Cancer Res. 47:1740.
10. Ebert, E. C., A. I. Roberts, S. M. O'Connell, and F. M. Robertson, H. Nagase. 1987. Characterisation of an immunosuppressive factor derived from human tumor cells. J. Immunol. 138:2161.
11. Mohagheghpour, N., B. Parhami, K. Dowlatshahi, D. Kadjehnouri, J. H. Elder, and F. V. Chisari. 1979. Immunoregulatory properties of human esophageal tumor extract. J. Immunol. 122:1350.
12. Skinner, D. B. 1983. En bloc resection for neoplasms of the esophagus and cardia. J. Thor. Cardiovasc. Surg. 85:59.
13. Reid, B. J. 1991. Esophageal tumors. In Textbook of Gastroenterology. T. Yamada, ed. J. B. Lippincott Co., Philadelphia, pp. 1159-1178.
14. Walsh, T. N., N. Noonan, D. Hollywood, A. Kelly, N. Keeling, and T. P. J. Hennessy. 1996. A comparison between multimodality therapy and surgery for esophageal adenocarcinoma. N. Engl. J. Med. 335:462.
15. Rosenberg, S. A., M. T. Lotze, L. M. Muul, A. E. Chang, F. P. Avis, S. Leitman, W. M. Linehan, C. N. Robertson, R. E. Lee, and J. T. Rubin. 1987. A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone. N. Engl. J. Med. 316:889.